These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2817909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
    Hara M, Nakamura T, Fujii Y.
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M, Ohta M, Muroi K, Takeda K, Kitagawa S, Tsuboyama A, Sakamoto S, Miura Y, Mutoh Y.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y, Irie S, Inagaki M, Fukumoto M, Ueda I, Ohmoto E, Fujimoto S, Endo Y, Watanabe S, Lai M, Takahashi I, Kimura I, Ishii H, Sezaki T.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
    Case DC, Sonneborn HL, Paul SD, Hiebel J, Boyd MA, Shepp MA, Dorsk BM, Bonnem E.
    Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
    Ohno R, Kimura K, Amaki I, Imamura Y, Masaoka T, Miyazaki T, Yoshida Y, Miura Y, Maekawa T, Oguro M.
    Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [New protocols for myeloma chemotherapy plus IFN alpha].
    Kitani T.
    Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 16. [Progress in the treatment of multiple myeloma].
    Wada M, Mizoguchi H.
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [Abstract] [Full Text] [Related]

  • 17. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P.
    Srp Arh Celok Lek; 1996 Jul; 124(11-12):292-6. PubMed ID: 9132962
    [Abstract] [Full Text] [Related]

  • 18. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [Abstract] [Full Text] [Related]

  • 19. Pegfilgrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient.
    Malerba L, Mele A, Leopardi G, Stramigioli S, Politi P, Visani G.
    Eur J Haematol; 2006 May; 76(5):436-9. PubMed ID: 16480428
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
    Wagstaff J, Loynds P, Scarffe JH.
    Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.